Clinical Trial Update: Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated aflibercept plus irinotecan and 5-FU versus placebo plus irinotecan and 5-FU in patients with metastatic colorectal cancer after ox…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• Camptosar (irinotecan)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Neoplasms, Neoplasm Metastasis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-28